CD44 and VEGF expression in extrahepatic metastasis of human hepatocellular carcinoma

被引:0
|
作者
Hirohashi, K [1 ]
Yamamoto, T [1 ]
Uenishi, T [1 ]
Ogawa, M [1 ]
Sakabe, K [1 ]
Takemura, S [1 ]
Shuto, T [1 ]
Tanaka, H [1 ]
Kubo, S [1 ]
Kinoshita, H [1 ]
机构
[1] Osaka City Univ, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan
关键词
hepatocellular carcinoma; extrahepatic metastasis; adhesion molecule; CD44; VEGF;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: We investigated the correlation between vascular endothelial growth factor (VEGF) and CD44 expression in hepatocellular carcinoma (HCC) and the frequency of extrahepatic metastasis, in order to evaluate the influence of vascular growth and adhesion molecules in facilitation of distant metastasis. Methodology: We obtained materials from primary lesions of HCC with no extrahepatic metastasis (control group) and primary lesions and metastatic lesions with extrahepatic metastasis (metastasis group). Immunohistochemical staining was performed using anti-human CD44v3 monoclonal antibodies and anti-human VEGF ab-3 monoclonal antibodies. Although pathological parameters such as tumor size, differentiation, capsule formation, and vascular invasion were analyzed, there was no marked difference among the groups. Results: Percentages of nodules with VEGF-positive tumor and sinusoidal cells were low in primary lesions of the control and metastasis groups, while high in metastatic lesions in the metastasis group. On the other hand, percentages of nodules with CD44-positive tumor and sinusoidal cells were low in primary lesions of the control group, while high in primary lesions and metastatic lesions of the metastasis group. Conclusions: The present study demonstrated that CD44 expression in primary lesions is related to a higher frequency of extrahepatic metastasis, suggesting that this is a clinicopathologically useful parameter in predicting the occurrence of distant metastasis.
引用
下载
收藏
页码:1121 / 1123
页数:3
相关论文
共 50 条
  • [1] EXPRESSION OF CD44 IN HUMAN HEPATOCELLULAR-CARCINOMA CELL-LINES
    HARAMAKI, M
    YANO, H
    FUKUDA, K
    MOMOSAKI, S
    OGASAWARA, S
    KOJIRO, M
    HEPATOLOGY, 1995, 21 (05) : 1276 - 1284
  • [2] Expression of splice variants of CD44 mRNA and its significance in human primary hepatocellular carcinoma
    刘鹏飞
    吴孟超
    陈汉
    钱光相
    傅继梁
    Chinese Medical Journal, 1998, (07)
  • [3] Expression of splice variants of CD44 mRNA and its significance in human primary hepatocellular carcinoma
    Liu, PF
    Wu, MC
    Chen, H
    Qian, GX
    Fu, JL
    CHINESE MEDICAL JOURNAL, 1998, 111 (07) : 603 - 605
  • [4] Expression of splice variants of CD44 mRNA and its significance in human primary hepatocellular carcinoma
    刘鹏飞
    吴孟超
    陈汉
    钱光相
    傅继梁
    中华医学杂志(英文版), 1998, (07) : 27 - 29
  • [5] CD44 AND METASTASIS
    ZOLLER, M
    KAUFMANN, M
    ONKOLOGIE, 1994, 17 (02): : 114 - 122
  • [6] Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression
    Rani, Bhavna
    Malfettone, Andrea
    Dituri, Francesco
    Soukupova, Jitka
    Lupo, Luigi
    Mancarella, Serena
    Fabregat, Isabel
    Giannelli, Gianluigi
    CELL DEATH & DISEASE, 2018, 9
  • [7] Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression
    Bhavna Rani
    Andrea Malfettone
    Francesco Dituri
    Jitka Soukupova
    Luigi Lupo
    Serena Mancarella
    Isabel Fabregat
    Gianluigi Giannelli
    Cell Death & Disease, 9
  • [8] Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma
    Yokoyama, Y
    Hiyama, E
    Murakami, Y
    Matsuura, Y
    Yokoyama, T
    CANCER, 1999, 86 (09) : 1691 - 1699
  • [9] Elucidating the functional role of CD44 in hepatocellular carcinoma
    Dhar, Debanjan
    Jiang, Yuhong
    He, Guobin
    Ogata, Hisanobu
    Font-Burgada, Joan
    Nakagawa, Hayato
    Seki, Ekihiro
    Karin, Michael
    HEPATOLOGY, 2012, 56 : 787A - 787A
  • [10] CD44 expression in human gliomas
    Ranuncolo, SM
    Ladeda, V
    Specterman, S
    Varela, M
    Lastiri, J
    Morandi, A
    Matos, E
    Joffe, EBD
    Puricelli, L
    Pallotta, MG
    JOURNAL OF SURGICAL ONCOLOGY, 2002, 79 (01) : 30 - 35